Your last version was released more than 3 months ago. Update your app with new features and/or some bug fixing.
Version 2017.4 released on December 10, 2017
iOS 11 is now supported.
You can now document a patient’s gender identity.
Lab Results Inbox
The label Assigned by, which appears when filtering lab results, is now Ordering Provider.
* Narcotic Addiction DEA Number (NADEAN) Support.
* Diagnoses. While writing a new prescription, you can now associate up to two diagnoses with a medication.
* Prescription change requests. You can now receive pharmacy requests to make changes to prescriptions, including requests for prior authorization and generic or therapeutic substitutions.
Version 2017.3.2 released on September 29, 2017
• Performance enhancements
Version 2017.3.0 released on September 17, 2017
Product Branding Changes
Earlier this year Quest Diagnostics announced that the Care360® name would transition to QuanumTM (Quest's brand name for its technology and data solutions). As you have already seen on the login screen, that time is here.
Quest is making this change to better align our technology under one brand and provide a more seamless experience for our customers. This name change will have no impact on your office workflow or experience using eLabs (for iPhone). All of the features and functionality that you have been using, will remain as is.
• Languages. The Preferred Language and Additional Language lists now include new languages. The language database now meets 2015 ONC Certification standards.
• Birth name. You can now document a patient's birth name.
• Sex. In addition to Male, Female, and Undifferentiated, you can now identify a patient as Unknown.
• Gender identity. You can now document a patient’s gender identity. You can choose one or more items from the list of gender identities, indicate that the patient has declined to specify a gender identity, or tap Gender category or other and add the information using free text.
• Sexual orientation. You can now document a patient’s sexual orientation. You can choose an item from the list of available sexual orientations, indicate that the patient has declined to specify a sexual orientation, or tap Something else and add the information using free text.
• Home phone number. The home phone number entered as part of patient demographics now appears on the patient's summary with new formatting. For example, 111-222-3333 4444. In the example, 4444 refers to an extension.
• Cell phone number. The cell phone number entered as part of patient demographics now appears on the patient's summary with new formatting. For example, 111-222-3333.
Note: Only one phone number appears on the patient's summary. By default, the home phone number appears. If no home phone number is available, then the cell phone number appears.
While writing a prescription, offers such as patient health information, eCopays, patient discount cards, or coupons are now available for some medications. If an offer is available for a medication, "Offer Available" appears once you select a dose form. When you are ready to approve the prescription, and depending on the type of offer, you can send it to the pharmacy and/or print a copy for the patient.
Version 2017.1 released on May 07, 2017
• Lab results that were previously identified as Critically Out of Range will now be referred to as Priority Out of Range.
• Pharmacy search (which is available when managing a patient’s pharmacies or when writing a prescription) now has additional search criteria when searching by pharmacy name. You can tap Exact, Starts With, Contains (default), or Sounds Like to indicate whether the phar macy name is an exact match to the characters entered or whether the pharmacy starts with, contains, or sounds like the characters entered.
• Schedule II-V (CII-V) Medications. Specifying directions is now required when prescribing CII-V medications. Directions can be entered using the Dosage Amount and Frequency or Manual Sig Entry.
• Schedule II (CII) Medications. Specifying a Duration is now required when prescribing CII medications and the value entered cannot be greater than 90 days.
• Schedule III-IV (CIII-IV) Medications: the maximum number of Refills that can be specified for CIII-IV medications is now
five, prescriptions for drugs requiring NADEAN (Narcotics Addiction DEA Number), such as buprenorphine, can no longer be sent electronically. These prescriptions must be printed and signed, and prescriptions for GHB (gammahydroxybutyric acid), such as Xyrem, can no longer be sent to pharmacy without adding a reason (medical need) in the Notes to Pharmacist box.
• The patient’s Summary now displays patient photo’s taken with Care360 HD
• Bug fixes & improvements